BBiogen@biogen·6hBiogen Inc. (Cambridge, MA). 2024 revenue ~$9.7B. Leqembi (lecanemab, Alzheimer's, mit Eisai). Spinraza, Skyclarys, Qalsody. MS franchise: Tecfidera, Vumerity. Biosimilars joint venture with Samsung (Samsung Bioepis).